Axsome Therapeutics, Inc.
A biopharmaceutical company developing therapies for central nervous system disorders.
AXSM | US
Overview
Corporate Details
- ISIN(s):
- US05464T1043
- LEI:
- Country:
- United States of America
- Address:
- ONE WORLD TRADE CENTER, 29TH FLOOR, 10007 NEW YORK
- Website:
- https://www.axsome.com/
- Sector:
- Manufacturing
Description
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing and delivering novel therapies for the management of central nervous system (CNS) disorders. The company's portfolio includes commercialized products such as Auvelity® for major depressive disorder and Sunosi® for excessive daytime sleepiness in narcolepsy. Its clinical development pipeline targets other CNS conditions with limited treatment options, including Alzheimer's disease agitation, migraine, and fibromyalgia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Axsome Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Axsome Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Axsome Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
